Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia

Neurology

Volumn 54, Issue 8, 2000, Pages 1616-1624

  Walker, M P ^a,d   Ayre, G A ^a   Cummings, J L ^a,b   Wesnes, K ^c   McKeith, I G ^a   O'Brien, J T ^a   Ballard, C G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Cognitive Drug Research Ltd ^*  (United Kingdom)

^d NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

AD; Attention; Dementia with Lewy bodies; EEG; Fluctuating cognition; Variability; Vascular dementia

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; HUMAN; HUMAN CELL; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RATING SCALE;

EID: 0034007962     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.8.1616     Document Type: Article

References (43)

1. Cummings JL, Benson DF. Dementia: definition, prevalence, classification and approach to diagnosis. In: Cummings JL, Benson DF, eds. Dementia: a clinical approach. Boston: Butterworth-Heineman, 1992.
2. Pearlin LI, Mullen JT, Semple SJ, et al. Caregiving and the stress process: an overview of concepts and their measures. Gerontology 1990;30:583-594.
3. Gray A, Fann P. Alzheimer's disease: the burden of illness in England. Health Trends 1993;20:31-37.
4. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-922.
5. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
6. Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.
7. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia - diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993; 43:250-260. Abstract.
8. Walker Z, Allen RL, Shergill S, Katona CLE. Neuropsychological performance in Lewy body dementia and Alzheimer's disease. Br J Psychiatry 1997;170:156-158.
9. McKeith IG, Ayre GA. Consensus criteria for the clinical diagnosis of dementia with Lewy bodies. In: Iqbal K, Winblad B, Nishimura T, Takeda M, Wisnieswski HM, eds. Alzheimer's disease: biology, diagnosis and therapeutics. New York: John Wiley & Sons, 1997:167-178.
10. Ayre G, Ballard C, Pincock C, McKeith I, Sahgal A, Wesnes K. Double dissociation between dementia with Lewy bodies and Alzheimer's disease on tests of attentional and mnemonic function: the role of the basal forebrain. J Psychopharmacol 1998;A12(suppl):A64.
11. Byrne EJ, Lennox G, Lowe J, Godwin-Austen RB. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989;52:709-717.
12. Kolbeinsson H, Jonsson A. Delirium and dementia in acute medical admissions of elderly patients in Iceland. Acta Psychiatrica Scand 1993;87:123-127.
13. Robertson B, Blennow K, Gottfries CG, Wallin A. Delirium in dementia. Int J Geriatr Psychiatry 1998;13:49-56.
14. Gibb WRG, Esiri MM, Lees AJ. Clinical and pathological features of diffuse Lewy body disease (Lewy body dementia). Brain 1987;110:1131-1153.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Standlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
16. Burns A, Russell E, Page S. New drugs for Alzheimer's disease. Br J Psychiatry 1999;174:476-479.
17. Meyer JS, Rodgers RL, McClintic K, et al. A randomized clinical trial of aspirin therapy in multi-infarct dementia. J Am Geriatr Soc 1989;37:549-555.
18. McKeith IG, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992;305:673-678.
19. McKeith IG, Ballard CG, Harrison RWS. Neuroleptic sensitivity to risperidone in Lewy body dementia. Lancet 1995; 346(8976):699.
20. Ballard C, Grace J, McKeith I, Holmes C. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease. Lancet 1998;351(9108):1032-1033.
21. Byrne EJ. Overview of differential diagnosis. Int Psychogeriatrics 1997;9(suppl 1):39-50.
22. Mega MS, Masterman DL Benson DF, et al. Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 1996;47:1403-1409.
23. Litvan I, MacIntyre A, Goetz CG, et al. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 1998;55:969-978.
24. McKeith IG, Ballard CG, Perry R, et al. Predictive accuracy of clinical diagnostic criteria for dementia with Lewy bodies - a prospective neuropathological validation study. Neurology 1998;50(suppl 4):181. Abstract.
25. Perry EK, Perry RH. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn 1995;28:240-258.
26. Walker MP, Ballard CG. Dementia with Lewy bodies. CNS 1998;47:1113-1124.
27. Binnie CD, Prior PF. Electroencephalography. J Neurol Neurosurg Psychiatry 1994;57:1308-1319.
28. Molinari L, Dumermuth G, Lange B. EEG-based multivariate statistical analysis of sleep stages. Neuropsychobiology 1984; 11:140-148.
29. Yamamoto T, Imai T. A case of diffuse Lewy body and Alzheimer's disease with periodic synchronous discharge. J Neuropathol Exp Neurol 1988;47:536-548.
30. Burkhardt CR, Filly CM, Kleinschmidt-De Masters BK, de la Monte S, Norenberg MD, Schneck SA. Diffuse Lewy body disease and progressive dementia. Neurology 1988;38:1520-1528.
31. Briel RC, McKeith IG, Barker WA, et al. EEG findings in dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999;66:401-403.
32. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
33. Dewey ME, Copeland JRM, Lobo A, Saz P, Dia J-L. Computerized diagnosis from a standardized history schedule: a preliminary communication about the organic section of the HASAGECAT system. Int J Geriatr Psychiatry 1992;7:443-446.
34. Fahn S, Elton R, Unified Parkinson's Disease Rating Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, eds. Recent developments in Parkinson's disease. New York: Macmillan, 1987:153-163.
35. Devanand DP, Miller L, Richards M, et al. The Columbia University Scale for Psychopathology in Alzheimer's Disease. Arch Neurol 1992;49:371-376.
36. Walker MP, Ayre GA, Ashton CH, et al. A pschophysiological investigation of fluctuating consciousness in neurodegenerative dementia. Hum Psychopharmacol 1999;14:483-489.
37. Simpson PM, Surmon DJ, Wesnes KA, Wilcock GK. The cognitive drug research computerized assessment system for demented patients: a validation study. Int J Geriatr Psychiatry 1991;6:95-102.
38. User's guide. Scan 4.0 EEG and evoked potential workstation manual, version II. Sterling, VA: Neuroscan Inc., 1993:144-145.
39. SPSS. Statistical Package for the Social Sciences. Windows version, release 5.0. Chicago: SPSS Inc., 1992.
40. Perry R, Walker M, Perry EK. Dementia with Lewy bodies: a new avenue for research into neurobiological mechanisms of consciousness? In: Fisher E, ed. Progress in Alzheimer's and Parkinson's disease. New York: Plenum, 1998:451-462.
41. Perry EK, Walker MP, Grace J, Perry R. Acetylcholine in mind: a neurotransmitter correlate of consciousness. Trends Neurosci 1999;22:273-280.
42. Kaufer DI, Catt KA, Lopez OL, DeKosky ST. Dementia with Lewy bodies: response of delirium-like features to donepezil. Neurology 1998;51:1512.
43. Pasquier F, Leys D. Why are stroke patients prone to develop dementia? J Neurol 1997;244:135-142.